Literature DB >> 33662672

The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective.

Jean Bousquet1, Marek Jutel2, Oliver Pfaar3, Joao A Fonseca4, Ioana Agache5, Wienczyslawa Czarlewski6, Claus Bachert7, Karl Christian Bergmann8, Alvaro A Cruz9, Ludger Klimek10, Violeta Kvedariene11, Désirée E Larenas-Linnemann12, Nikolaos G Papadopoulos13, Vincenzo Patella14, Frederico S Regateiro15, Nicola Scichilone16, Mohamed H Shamji17, Aziz Sheikh18, Erkka Valovirta19, Maria-Teresa Ventura20, Torsten Zuberbier8.   

Abstract

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis and/or asthma. Many international or national practice guidelines have been produced, but the evidence-based method varies and they do not usually propose care pathways. The present article considers the possible role of mobile health in AIT for allergic rhinitis/asthma. There are no currently available validated biologic biomarkers that can predict AIT success, and mobile health biomarkers have some relevance. In the current article, the following aspects will be discussed: patient stratification for AIT, symptom-medication scores for the follow-up of patients, clinical trials, as well as the approach of the European Academy of Allergy and Clinical Immunology.
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARIA; Allergic rhinitis; EAACI; Immunotherapy; mHealth

Year:  2021        PMID： 33662672     DOI： 10.1016/j.jaip.2021.02.035

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  4 in total

1.  Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD).

Authors:  Oliver Pfaar; Tobias Ankermann; Matthias Augustin; Petra Bubel; Sebastian Böing; Randolf Brehler; Peter A Eng; Peter J Fischer; Michael Gerstlauer; Eckard Hamelmann; Thilo Jakob; Jörg Kleine-Tebbe; Matthias Volkmar Kopp; Susanne Lau; Norbert Mülleneisen; Christoph Müller; Katja Nemat; Wolfgang Pfützner; Joachim Saloga; Klaus Strömer; Peter Schmid-Grendelmeier; Antje Schuster; Gunter Johannes Sturm; Christian Taube; Zsolt Szépfalusi; Christian Vogelberg; Martin Wagenmann; Wolfgang Wehrmann; Thomas Werfel; Stefan Wöhrl; Margitta Worm; Bettina Wedi; Susanne Kaul; Vera Mahler; Anja Schwalfenberg
Journal:  Allergol Select       Date:  2022-09-06

2.  Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model.

Authors:  Bernardo Sousa-Pinto; Luís Filipe Azevedo; Ana Sá-Sousa; Rafael José Vieira; Rita Amaral; Ludger Klimek; Wienczyslawa Czarlewski; Josep M Anto; Anna Bedbrook; Violeta Kvedariene; Maria Teresa Ventura; Ignacio J Ansotegui; Karl-Christian Bergmann; Luisa Brussino; G Walter Canonica; Victoria Cardona; Pedro Carreiro-Martins; Thomas Casale; Lorenzo Cecchi; Tomás Chivato; Derek K Chu; Cemal Cingi; Elisio M Costa; Alvaro A Cruz; Giulia De Feo; Philippe Devillier; Wytske J Fokkens; Mina Gaga; Bilun Gemicioğlu; Tari Haahtela; Juan Carlos Ivancevich; Zhanat Ispayeva; Marek Jutel; Piotr Kuna; Igor Kaidashev; Helga Kraxner; Désirée E Larenas-Linnemann; Daniel Laune; Brian Lipworth; Renaud Louis; Michaël Makris; Riccardo Monti; Mario Morais-Almeida; Ralph Mösges; Joaquim Mullol; Mikaëla Odemyr; Yoshitaka Okamoto; Nikolaos G Papadopoulos; Vincenzo Patella; Nhân Pham-Thi; Frederico S Regateiro; Sietze Reitsma; Philip W Rouadi; Boleslaw Samolinski; Milan Sova; Ana Todo-Bom; Luis Taborda-Barata; Peter Valentin Tomazic; Sanna Toppila-Salmi; Joaquin Sastre; Ioanna Tsiligianni; Arunas Valiulis; Dana Wallace; Susan Waserman; Arzu Yorgancioglu; Mihaela Zidarn; Torsten Zuberbier; João Almeida Fonseca; Jean Bousquet; Oliver Pfaar
Journal:  Clin Transl Allergy       Date:  2022-03       Impact factor: 5.871

Review 3.  mHealth and telemedicine utility in the monitoring of allergic diseases.

Authors:  Violeta Kvedarienė; Paulina Burzdikaitė; Inga Česnavičiūtė
Journal:  Front Allergy       Date:  2022-09-02

4.  Heterogeneous validity of daily data on symptoms of seasonal allergic rhinitis recorded by patients using the e-diary AllergyMonitor®.

Authors:  Stephanie Dramburg; Serena Perna; Marco Di Fraia; Salvatore Tripodi; Stefania Arasi; Sveva Castelli; Danilo Villalta; Francesca Buzzulini; Ifigenia Sfika; Valeria Villella; Ekaterina Potapova; Maria Antonia Brighetti; Alessandro Travaglini; Pier Luigi Verardo; Simone Pelosi; Paolo Maria Matricardi
Journal:  Clin Transl Allergy       Date:  2021-12-15       Impact factor: 5.871
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.